Pharmacokinetics and Bioequivalence of Ambroxol Hydrochloride Granules
Kun Niu
Abstract
Kun Niu
Abstract
The pharmacokinetics of ambroxol hydrochloride granules and reference tablets were investigated at a single oral dosage of 30mg in 19 healthy male volunteers,according to a randomized crossover design.The concentration of ambroxol in plasma was determined by a LC-MS/MS method.The main pharmacokinetic parameters of test and reference preparations were cmax(69.66±22.12) and(67.89±25.08)ng/ml,tmax(1.95±0.60) and(1.89±0.43)h,t1/2(7.77±0.93) and(7.61±1.02)h,AUC0→24h(517.9±180.4) and(518.3±215.5)ng.h.ml–1.The relative bioavailability of ambroxol hydrochloride granules was(102.7±17.1)%.The result of two one-side t test showed that the two preparations were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The pharmacokinetics of ambroxol hydrochloride granules and reference tablets were investigated at a single oral dosage of 30mg in 19 healthy male volunteers,according to a randomized crossover design.The concentration of ambroxol in plasma was determined by a LC-MS/MS method.The main pharmacokinetic parameters of test and reference preparations were cmax(69.66±22.12) and(67.89±25.08)ng/ml,tmax(1.95±0.60) and(1.89±0.43)h,t1/2(7.77±0.93) and(7.61±1.02)h,AUC0→24h(517.9±180.4) and(518.3±215.5)ng.h.ml–1.The relative bioavailability of ambroxol hydrochloride granules was(102.7±17.1)%.The result of two one-side t test showed that the two preparations were bioequivalent.
Key concepts: Bioequivalence, Ambroxol, Cmax, Pharmacokinetics, Chemistry, Bioavailability, Crossover study, Pharmacology